eosinophilic granulomatosis with polyangiitis
GPTKB entity
Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:microscopic_polyangiitis
gptkb:Nucala gptkb:interleukin-5 |
| gptkbp:affects |
gptkb:skincare_product
lungs blood vessels nerves |
| gptkbp:associated_with |
eosinophilia
ANCA antibodies |
| gptkbp:caused_by |
autoimmune response
|
| gptkbp:clinical_trial |
biomarkers
patient outcomes disease management new therapies |
| gptkbp:complications |
lung damage
heart problems kidney damage neuropathy gastrointestinal issues |
| gptkbp:current_use |
gptkb:musician
gptkb:Churg-Strauss_syndrome |
| gptkbp:first_described_by |
1951
|
| gptkbp:gender |
more common in males
|
| https://www.w3.org/2000/01/rdf-schema#label |
eosinophilic granulomatosis with polyangiitis
|
| gptkbp:is_popular_in |
rare
|
| gptkbp:premiered_on |
adulthood
|
| gptkbp:related_to |
autoimmune diseases
eosinophilic disorders systemic vasculitis |
| gptkbp:research_focus |
genetic factors
environmental triggers long-term outcomes treatment options pathogenesis |
| gptkbp:social_responsibility |
variable
blood tests biopsy depends on severity depends on treatment eosinophilia ANCA positivity tissue biopsy showing vasculitis |
| gptkbp:symptoms |
gptkb:asthma
fatigue weight loss fever sinusitis |
| gptkbp:treatment |
antibiotics
supportive care biologics corticosteroids plasma exchange immunosuppressants |